Abstract
In recent years, the number of useful chemical biology information of protein-protein interactions in the HIV life cycle and related inhibitors, is growing rapidly, which makes protein-protein interactions a new investigative area for antiviral drug intervention. This review will summarize recent work in this field, mainly focusing on the utilization of small molecules targeted against a variety of protein-protein interactions that have great therapeutic feasibility for HIV infection, and lastly outline some other important protein-protein interactions with a potential to advance into novel anti- HIV drug targets in future.
Keywords: HIV, AIDS, drug design, drug targets, protein-protein interactions, inhibitor, Anti-HIV, anti-AIDS, reverse transcriptase, protease, integrase, CCR5 coreceptor, HAART), capsid protein, NF-B, Rev protein, RNase H, TEFb, allosteric site, GP120, –, CD4, (ELISA), Schiffs base linkage, Bris-tol-Myers Squibb, clinical trials, HIV-1 inhibition, MAPPIT, HIV enzymes, Dimerization Inhibitors, HIV therapy, peptidomimetics, PR dimerization inhibitors, SAR, VIF-APOBEC3G, LEDGF/p75, CHIBA-3003, SQs, cell-based assays, (Vpr), Gag, GAG-TSG101, CRM1-NES
Current Medicinal Chemistry
Title: Targeting Protein-Protein Interactions: A Promising Avenue of Anti-HIV Drug Discovery
Volume: 17 Issue: 29
Author(s): Peng Zhan, Wenjun Li, Hongfei Chen and Xinyong Liu
Affiliation:
Keywords: HIV, AIDS, drug design, drug targets, protein-protein interactions, inhibitor, Anti-HIV, anti-AIDS, reverse transcriptase, protease, integrase, CCR5 coreceptor, HAART), capsid protein, NF-B, Rev protein, RNase H, TEFb, allosteric site, GP120, –, CD4, (ELISA), Schiffs base linkage, Bris-tol-Myers Squibb, clinical trials, HIV-1 inhibition, MAPPIT, HIV enzymes, Dimerization Inhibitors, HIV therapy, peptidomimetics, PR dimerization inhibitors, SAR, VIF-APOBEC3G, LEDGF/p75, CHIBA-3003, SQs, cell-based assays, (Vpr), Gag, GAG-TSG101, CRM1-NES
Abstract: In recent years, the number of useful chemical biology information of protein-protein interactions in the HIV life cycle and related inhibitors, is growing rapidly, which makes protein-protein interactions a new investigative area for antiviral drug intervention. This review will summarize recent work in this field, mainly focusing on the utilization of small molecules targeted against a variety of protein-protein interactions that have great therapeutic feasibility for HIV infection, and lastly outline some other important protein-protein interactions with a potential to advance into novel anti- HIV drug targets in future.
Export Options
About this article
Cite this article as:
Zhan Peng, Li Wenjun, Chen Hongfei and Liu Xinyong, Targeting Protein-Protein Interactions: A Promising Avenue of Anti-HIV Drug Discovery, Current Medicinal Chemistry 2010; 17 (29) . https://dx.doi.org/10.2174/092986710793176357
DOI https://dx.doi.org/10.2174/092986710793176357 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy
Current Drug Metabolism Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design The Apoptotic Pathway as a Therapeutic Target in Sepsis
Current Drug Targets Exploring Current Role of Nanotechnology Used in Food Processing Industry to Control Food Additives and their Biochemical Mechanisms
Current Drug Targets Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets
Current Medicinal Chemistry Evaluation of Micro-RNA Levels, Apoptosis and Oxidative Stress Markers in Patients Recieving Chemotherapy
Combinatorial Chemistry & High Throughput Screening Glucose Blood Levels as a Therapeutic Target in Acute Ischaemic Stroke Setting
Current Topics in Medicinal Chemistry Psoriasin, A Multifunctional Player in Different Diseases
Current Protein & Peptide Science Protein Arginine Methyltransferase 1 and its Dynamic Regulation Associated with Cellular Processes and Diseases
Protein & Peptide Letters Impact of Metformin on Male Reproduction
Current Pharmaceutical Design Toxicity of Carbon Nanotubes
Current Drug Metabolism Protein Oxidative Modification in the Aging Organism and the Role of the Ubiquitin Proteasomal System
Current Pharmaceutical Design The Neurotrophic and Antiangiogenic Functions of PEDF: A Reflection of its Variable Phosphorylation States
Current Genomics Mass Spectrometry Imaging: Applications in Drug Distribution Studies
Current Drug Metabolism The Emerging Role of the Endocannabinoid System in the Sleep-Wake Cycle Modulation
Central Nervous System Agents in Medicinal Chemistry Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies
Current Pharmaceutical Design Cellular Senescence in Ageing, Age-Related Disease and Longevity
Current Vascular Pharmacology Tackling Chronic Pain and Inflammation through the Purinergic System
Current Medicinal Chemistry Design and Endpoints of Clinical and Translational Trials in Advanced Colorectal Cancer. A Proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD)
Reviews on Recent Clinical Trials Different Concepts of Drug Delivery in Disease Entities
Mini-Reviews in Medicinal Chemistry